HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jo Lambert Selected Research
Jo Lambert Research Topics
Disease
34
Psoriasis (Pustulosis Palmaris et Plantaris)
12/2023 - 10/2010
8
Neoplasms (Cancer)
04/2023 - 09/2008
8
Vitiligo
01/2019 - 03/2009
7
Melanoma (Melanoma, Malignant)
04/2013 - 09/2008
4
Neoplasm Metastasis (Metastasis)
04/2013 - 09/2008
3
Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
04/2024 - 01/2019
3
Infections
04/2023 - 11/2017
3
COVID-19
01/2023 - 01/2021
3
Hyperpigmentation
07/2014 - 04/2006
2
Psoriatic Arthritis
01/2022 - 01/2019
2
Rheumatoid Arthritis
01/2022 - 01/2022
2
Blister (Bulla)
01/2019 - 03/2009
2
Skin Diseases (Skin Disease)
01/2019 - 03/2016
2
Alopecia Areata
01/2019 - 01/2016
2
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2017 - 09/2008
2
Carcinogenesis
01/2017 - 04/2013
2
Contact Dermatitis (Eczema, Contact)
01/2016 - 09/2013
2
Lymphatic Metastasis
06/2010 - 09/2008
1
Necrosis
01/2022
1
Junctional Epidermolysis Bullosa (Epidermolysis Bullosa Letalis)
03/2021
1
Pain (Aches)
12/2020
1
Ankylosing Spondylitis
01/2019
1
Bullous Pemphigoid (Pemphigoid)
01/2019
1
Injection Site Reaction
11/2017
1
Obesity
11/2017
1
Cholangiocarcinoma
01/2017
1
Disease Progression
11/2016
1
Multiple Sclerosis
01/2015
1
Hemophilia A (Haemophilia)
01/2015
1
Hypertrophic Cicatrix (Hypertrophic Scar)
03/2013
1
Anaphylaxis (Anaphylactic Shock)
12/2012
1
Nevus (Nevi)
11/2011
1
Breast Neoplasms (Breast Cancer)
06/2010
Drug/Important Bio-Agent (IBA)
6
Proteins (Proteins, Gene)
FDA Link
01/2017 - 06/2009
5
Adalimumab (Humira)
FDA Link
11/2023 - 06/2015
5
Methotrexate (Mexate)
FDA Link
Generic
11/2023 - 11/2017
5
Small Interfering RNA (siRNA)
IBA
01/2018 - 10/2008
4
Ustekinumab (CNTO 1275)
FDA Link
08/2021 - 01/2019
3
Prostaglandins A
IBA
12/2023 - 01/2020
3
apremilast
IBA
12/2023 - 01/2022
3
secukinumab
IBA
07/2022 - 10/2019
2
Immunomodulating Agents
IBA
04/2024 - 01/2023
2
Interleukin-17 (Interleukin 17)
IBA
04/2023 - 01/2019
2
Biomarkers (Surrogate Marker)
IBA
11/2016 - 04/2016
2
MicroRNAs (MicroRNA)
IBA
04/2016 - 04/2013
2
Antibodies
IBA
01/2015 - 12/2013
2
Adrenal Cortex Hormones (Corticosteroids)
IBA
12/2012 - 03/2009
2
Antigens
IBA
11/2011 - 06/2010
2
Messenger RNA (mRNA)
IBA
06/2010 - 06/2009
2
Monophenol Monooxygenase (Tyrosinase)
IBA
06/2010 - 05/2010
1
Infliximab (Remicade)
FDA Link
04/2024
1
deucravacitinib
IBA
12/2023
1
TYK2 Kinase (Tyrosine Kinase 2)
IBA
12/2023
1
tildrakizumab
IBA
01/2023
1
Horseradish Peroxidase
IBA
07/2022
1
guselkumab
IBA
09/2021
1
brodalumab
IBA
08/2021
1
Collagen Type XVII
IBA
03/2021
1
Antisense Oligonucleotides
IBA
03/2021
1
Immunosuppressive Agents (Immunosuppressants)
IBA
01/2021
1
4-amino-4'-hydroxylaminodiphenylsulfone (HADS)
IBA
12/2020
1
risankizumab
IBA
12/2020
1
HLA-C*06 antigen
IBA
10/2019
1
Omalizumab (Xolair)
FDA Link
01/2019
1
Immunoglobulin E (IgE)
IBA
01/2019
1
Tumor Necrosis Factor Inhibitors
IBA
11/2017
1
Transaminases (Aminotransferases)
IBA
11/2017
1
Folic Acid (Vitamin M)
FDA Link
Generic
11/2017
1
anthracene
IBA
01/2017
1
beta-Defensins
IBA
03/2016
1
Liposomes (Liposome)
IBA
03/2016
1
tofacitinib
IBA
01/2016
1
Janus Kinase Inhibitors
IBA
01/2016
1
Factor VIII (Coagulation Factor VIII)
IBA
01/2015
1
Interferons
IBA
01/2015
1
Melanins (Melanin)
IBA
07/2014
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
12/2013
1
Volatile Oils (Essential Oils)
IBA
09/2013
1
N-phthaloylglutamic acid
IBA
03/2013
1
Polyethylene Glycols (Polyethylene Glycol)
FDA Link
Generic
12/2012
1
Enzymes
IBA
09/2012
1
Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)
IBA
09/2012
1
A-factor (Streptomyces)
IBA
09/2012
1
Differentiation Antigens
IBA
11/2011
1
ErbB Receptors (EGF Receptor)
IBA
06/2011
1
Cetuximab (Erbitux)
FDA Link
06/2011
1
lissamine rhodamine B (sulforhodamine B)
IBA
06/2011
1
matrigel
IBA
06/2011
1
RNA (Ribonucleic Acid)
IBA
06/2010
Therapy/Procedure
18
Therapeutics
08/2023 - 03/2009
3
Biological Therapy
08/2021 - 06/2015
2
Activities of Daily Living (ADL)
09/2023 - 01/2022
1
Off-Label Use
01/2019
1
Phototherapy (Light Therapy)
11/2017
1
Skin Care
08/2016
1
RNAi Therapeutics
03/2016
1
Intravitreal Injections
01/2016
1
Lasers (Laser)
03/2013
1
Cryotherapy (Therapy, Cold)
01/2012
1
Laser Therapy (Surgery, Laser)
01/2012